Maxigen Biotech Inc. (1783.TW)
TWD 46.3
(-0.43%)
TWD 46.3
(-0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 622.11 Million | 604.43 Million | 511.97 Million | 457.69 Million | 452.19 Million | 427.68 Million |
| Cost of Revenue | 198.02 Million | 230.43 Million | 250.94 Million | 243.17 Million | 234.92 Million | 245.11 Million |
| Gross Profit | 424.09 Million | 373.99 Million | 261.02 Million | 214.52 Million | 217.27 Million | 182.56 Million |
| Operating Expenses | 274.24 Million | 240.66 Million | 168.05 Million | 153.51 Million | 151.78 Million | 136.43 Million |
| Selling, General and Administrative Expenses | 205.64 Million | 141.02 Million | 92.37 Million | 84.36 Million | 84.92 Million | 85.76 Million |
| Research and Development Expenses | 68.59 Million | 99.63 Million | 75.68 Million | 69.15 Million | 66.86 Million | 50.67 Million |
| Other Expenses | - | 34.05 Million | 7.23 Million | 15.1 Million | 10.6 Million | 15.13 Million |
| Cost and Expenses | 472.26 Million | 471.09 Million | 419 Million | 396.68 Million | 386.7 Million | 381.55 Million |
| Operating Income | 149.85 Million | 170.56 Million | 100.68 Million | 76.88 Million | 76.09 Million | 46.12 Million |
| Interest Expense | - | 68 Thousand | 196 Thousand | 250 Thousand | 3.43 Million | 4.01 Million |
| Income Tax Expense | 27.31 Million | 26.37 Million | 9.79 Million | 13.42 Million | 12.68 Million | 253 Thousand |
| Earnings before Tax | 193.14 Million | 165.78 Million | 97.46 Million | 76.73 Million | 72.79 Million | 57.3 Million |
| Net Income | 165.82 Million | 139.4 Million | 87.66 Million | 63.31 Million | 60.11 Million | 57.05 Million |
| Earnings Per Share Basic | 1.86 | 1.57 | 1.05 | 0.79 | 0.75 | 0.67 |
| Earnings Per Share Diluted | 1.85 | 1.56 | 1.04 | 0.79 | 0.71 | 0.67 |
| Weighted Average Shares Outstanding | 88.93 Million | 88.93 Million | 83.76 Million | 80.23 Million | 80.23 Million | 84.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 89.45 Million | 89.41 Million | 84.06 Million | 80.63 Million | 87.83 Million | 85.32 Million |
| Gross Margin | 0.68 | 0.62 | 0.51 | 0.47 | 0.48 | 0.43 |
| EBIT Margin | 0.28 | 0.33 | 0.26 | 0.24 | 0.24 | 0.20 |
| Profit Margin | 0.27 | 0.23 | 0.17 | 0.14 | 0.13 | 0.13 |
| EBITDA | 177.09 Million | 200.14 Million | 133.58 Million | 110.08 Million | 108.68 Million | 87.53 Million |
| Earnings Before Tax Margin | 0.24 | 0.28 | 0.20 | 0.17 | 0.17 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 174.01 Million | 127.05 Million | 148.74 Million | 622.11 Million | 159.42 Million | 170.91 Million |
| Cost of Revenue | 57.82 Million | 39.44 Million | 46.18 Million | 198.02 Million | 50.8 Million | 54.7 Million |
| Gross Profit | 116.19 Million | 87.61 Million | 102.55 Million | 424.09 Million | 108.62 Million | 116.21 Million |
| Operating Expenses | 75.82 Million | 62.27 Million | 69.16 Million | 274.24 Million | 82.8 Million | 63 Million |
| Selling, General and Administrative Expenses | 48.02 Million | 40.79 Million | 50.91 Million | - | 57.42 Million | 51.32 Million |
| Research and Development Expenses | 24.78 Million | 21.48 Million | 18.05 Million | - | 25.38 Million | 11.67 Million |
| Other Expenses | -75.82 Million | 11.34 Million | -69.16 Million | -274.24 Million | 25.95 Million | 4.44 Million |
| Cost and Expenses | 133.64 Million | 101.72 Million | 115.34 Million | 472.26 Million | 133.6 Million | 117.7 Million |
| Operating Income | 40.37 Million | 25.33 Million | 33.39 Million | 149.85 Million | 55.05 Million | 60.95 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -12.4 Million | 10.85 Million | 6.06 Million | 27.31 Million | 13.69 Million | -1.39 Million |
| Earnings before Tax | 47.33 Million | 39.27 Million | 23.72 Million | 193.14 Million | 55.05 Million | 60.95 Million |
| Net Income | 59.73 Million | 28.41 Million | 17.66 Million | 165.82 Million | 41.36 Million | 62.34 Million |
| Earnings Per Share Basic | 0.67 | 0.32 | 0.20 | - | 0.47 | 0.70 |
| Earnings Per Share Diluted | 0.66 | 0.32 | 0.20 | - | 0.46 | 0.70 |
| Weighted Average Shares Outstanding | 90.5 Million | 88.07 Million | 88.93 Million | 88.93 Million | 88.93 Million | 88.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 90.5 Million | 88.54 Million | 90.16 Million | 89.45 Million | 89.04 Million | 89.04 Million |
| Gross Margin | 0.67 | 0.69 | 0.69 | 0.68 | 0.68 | 0.68 |
| EBIT Margin | 0.31 | 0.25 | 0.21 | - | 0.39 | 0.40 |
| Profit Margin | 0.34 | 0.22 | 0.12 | 0.27 | 0.26 | 0.36 |
| EBITDA | 53.09 Million | 31.84 Million | 30.57 Million | - | 62.24 Million | 67.85 Million |
| Earnings Before Tax Margin | 0.23 | 0.20 | 0.22 | 0.24 | 0.35 | 0.36 |
DC
1203
4769
HLNE
SFBI
EUROTEXIND